Hesitancy and reactogenicity to mRNA-based COVID-19 vaccines–Early experience with vaccine rollout in a multi-site healthcare system

BACKGROUND: Hesitancy and incomplete vaccination against coronavirus disease 2019 (COVID-19) remains an obstacle to achieving herd immunity. Because of fear of vaccine reactions, patients with medical and allergic co-morbidities express heightened hesitancy. Limited information is available to guide...

Descripción completa

Detalles Bibliográficos
Autores principales: Al-Obaydi, Sarah, Hennrikus, Eileen, Mohammad, Nazar, Lehman, Erik B., Thakur, Abhishek, Al-Shaikhly, Taha
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9355214/
https://www.ncbi.nlm.nih.gov/pubmed/35930586
http://dx.doi.org/10.1371/journal.pone.0272691

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9355214/
https://www.ncbi.nlm.nih.gov/pubmed/35930586
http://dx.doi.org/10.1371/journal.pone.0272691

Ejemplares similares